TheraPEP® Positive Expired Pressure Therapy Device

The TheraPEP® System is the proven choice for secretion clearance and reversal of atelectasis ^{1 2}

TheraPEP® PEP Therapy System is the easy-to-use system for mobilising secretions in patients with cystic fibrosis (CF), lung diseases with secretory problems and to prevent or reverse atelectasis, as well as patients recovering from surgery.
Designed for positive expiratory pressure therapy and simultaneous aerosol drug delivery, the TheraPEP® System can help virtually any patient mobilise secretions easily, conveniently, and cost-effectively.
Positive expiratory pressure (PEP) therapy with TheraPEP® PEP Therapy System, unlike labour-intensive, time-consuming chest physiotherapy (CPT), can be self-administered by the patient in any setting, helping patients maintain an effective continuum of care outside the hospital. The TheraPEP® System may reduce the need for postural drainage and percussion, and can be performed in less than half the time of a conventional CPT session. ³ This offers significant time savings for both patients and clinicians.
The TheraPEP® System is even more efficient when used with a medication nebuliser or MDI spacer. The patient can receive aerolised medication, and perform therapy for secretion clearance and atelectasis, in the time of one treatment. PEP therapy may also optimise delivery of bronchodilators in patients receiving bronchial hygiene therapy. ⁴ No other secretion clearance device offers you a better combination of therapy, flexibility and efficiency.

Features

• Six fixed orifice options
• Built-in durable pressure indicator
• 22mm OD patient end
• Inspiratory valve

Benefits

• Can accommodate virtually any patient’s lung capacity
• Resist breakage, unlike fragile, costly manometers
• Provides immediate, visual 360º feedback of prescribed pressure
• May be used with a mask, mouthpiece or nebuliser
• Allows inhalation and exhalation with removing form mouth

1. _{McIlwaine PM, Wong LT, Peacock D, Davidson GF. Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis. J Pediatr. October 1997.}
2. _{Protocol of the Month, University of Pittsburgh Medical Center, Department of Respiratory Care. AARC Times, May 1997.}
3. _{Mahlmeister MJ, Fink JB, Hoffman GL, Fifer LF. “Positive-expiratory-pressure mask therapy: Theoretical and Practical Considerations and a Review of the Literature”, Respiratory Care, 1991;36:1218-1230.}
4. _{“AARC Clinical Practice: ‘Use of Positive Airway Pressure Adjuncts to Bronchial Hygiene Therapy’,” Respiratory Care, 1993;38:516-521.}